skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:029825/0070   Pages: 7
Recorded: 02/18/2013
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 30
1
Patent #:
5932448
Issue Dt:
08/03/1999
Application #:
07801798
Filing Dt:
11/29/1991
Title:
BISPECIFIC ANTIBODY HETERODIMERS
2
Patent #:
5834597
Issue Dt:
11/10/1998
Application #:
08656586
Filing Dt:
05/31/1996
Title:
MUTATED NONACTIVATING IGG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
3
Patent #:
6013256
Issue Dt:
01/11/2000
Application #:
08934841
Filing Dt:
09/22/1997
Title:
METHOD OF PREVENTING ACUTE REJECTION FOLLOWING SOLID ORGAN TRANSPLANTATION
4
Patent #:
6762020
Issue Dt:
07/13/2004
Application #:
09642034
Filing Dt:
08/18/2000
Title:
METHODS OF DIAGNOSING BREAST CANCER
5
Patent #:
6649342
Issue Dt:
11/18/2003
Application #:
09657960
Filing Dt:
09/08/2000
Title:
NOVEL METHODS OF DIAGNOSING BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR BREAST CANCER MODULATORS
6
Patent #:
6780586
Issue Dt:
08/24/2004
Application #:
09702216
Filing Dt:
10/30/2000
Title:
METHODS OF DIAGNOSING BREAST CANCER
7
Patent #:
7276589
Issue Dt:
10/02/2007
Application #:
10724274
Filing Dt:
11/26/2003
Publication #:
US20050054834
Pub Dt:
03/10/2005
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
8
Patent #:
7285268
Issue Dt:
10/23/2007
Application #:
10830956
Filing Dt:
04/23/2004
Publication #:
US20050163769
Pub Dt:
07/28/2005
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
9
Patent #:
7217798
Issue Dt:
05/15/2007
Application #:
10966673
Filing Dt:
10/15/2004
Publication #:
US20050226864
Pub Dt:
10/13/2005
Title:
ALTERATION OF FC-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS
10
Patent #:
7592004
Issue Dt:
09/22/2009
Application #:
11250835
Filing Dt:
10/14/2005
Publication #:
US20060029599
Pub Dt:
02/09/2006
Title:
STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION OF IGG ANTIBODIES
11
Patent #:
7732570
Issue Dt:
06/08/2010
Application #:
11803694
Filing Dt:
05/14/2007
Publication #:
US20080287657
Pub Dt:
11/20/2008
Title:
ALTERATION OF FC-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS
12
Patent #:
7824678
Issue Dt:
11/02/2010
Application #:
11837337
Filing Dt:
08/10/2007
Publication #:
US20080160012
Pub Dt:
07/03/2008
Title:
ANTIBODIES AGAINST CANCER ANTIGEN TMEFF2 AND USES THEREOF
13
Patent #:
7879987
Issue Dt:
02/01/2011
Application #:
11840854
Filing Dt:
08/17/2007
Publication #:
US20090259031
Pub Dt:
10/15/2009
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
14
Patent #:
7776585
Issue Dt:
08/17/2010
Application #:
11840863
Filing Dt:
08/17/2007
Publication #:
US20080026458
Pub Dt:
01/31/2008
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
15
Patent #:
7897148
Issue Dt:
03/01/2011
Application #:
11852147
Filing Dt:
09/07/2007
Publication #:
US20080260732
Pub Dt:
10/23/2008
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
16
Patent #:
7947495
Issue Dt:
05/24/2011
Application #:
12263272
Filing Dt:
10/31/2008
Publication #:
US20090136950
Pub Dt:
05/28/2009
Title:
IMMUNOGLOBULIN DISPLAY VECTORS
17
Patent #:
NONE
Issue Dt:
Application #:
12340199
Filing Dt:
12/19/2008
Publication #:
US20130338038
Pub Dt:
12/19/2013
Title:
METHOD OF SCREENING COMPLEX PROTEIN LIBRARIES TO IDENTIFY ALTERED PROPERTIES
18
Patent #:
8633139
Issue Dt:
01/21/2014
Application #:
12340279
Filing Dt:
12/19/2008
Publication #:
US20130338017
Pub Dt:
12/19/2013
Title:
METHODS OF SCREENING COMPLEX PROTEIN LIBRARIES TO IDENTIFY ALTERED PROPERTIES
19
Patent #:
8088898
Issue Dt:
01/03/2012
Application #:
12397026
Filing Dt:
03/03/2009
Publication #:
US20090246852
Pub Dt:
10/01/2009
Title:
THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
20
Patent #:
8298530
Issue Dt:
10/30/2012
Application #:
12540320
Filing Dt:
08/12/2009
Publication #:
US20100055097
Pub Dt:
03/04/2010
Title:
STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION OF IGG ANTIBODIES
21
Patent #:
8163546
Issue Dt:
04/24/2012
Application #:
12748247
Filing Dt:
03/26/2010
Publication #:
US20110008883
Pub Dt:
01/13/2011
Title:
MAMMALIAN CELL-BASED IMMUNOGLOBULIN DISPLAY LIBRARIES
22
Patent #:
8624007
Issue Dt:
01/07/2014
Application #:
12751914
Filing Dt:
03/31/2010
Publication #:
US20110183412
Pub Dt:
07/28/2011
Title:
ALTERATION OF FC-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS
23
Patent #:
8313745
Issue Dt:
11/20/2012
Application #:
12796244
Filing Dt:
06/08/2010
Publication #:
US20110117013
Pub Dt:
05/19/2011
Title:
COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF
24
Patent #:
8309084
Issue Dt:
11/13/2012
Application #:
13009757
Filing Dt:
01/19/2011
Publication #:
US20110300133
Pub Dt:
12/08/2011
Title:
CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS
25
Patent #:
8642557
Issue Dt:
02/04/2014
Application #:
13046498
Filing Dt:
03/11/2011
Publication #:
US20110305712
Pub Dt:
12/15/2011
Title:
CTLA4 PROTEINS AND THEIR USES
26
Patent #:
8283170
Issue Dt:
10/09/2012
Application #:
13090065
Filing Dt:
04/19/2011
Publication #:
US20110250611
Pub Dt:
10/13/2011
Title:
IMMUNOGLOBULIN DISPLAY VECTORS
27
Patent #:
8603477
Issue Dt:
12/10/2013
Application #:
13126754
Filing Dt:
04/28/2011
Publication #:
US20110206701
Pub Dt:
08/25/2011
Title:
USE OF ANTI-CS1 ANTIBODIES FOR TREATMENT OF RARE LYMPHOMAS
28
Patent #:
8465739
Issue Dt:
06/18/2013
Application #:
13226372
Filing Dt:
09/06/2011
Publication #:
US20110318343
Pub Dt:
12/29/2011
Title:
STABLE AQUEOUS PHARMACEUTICAL FORMULATIONS OF DACLIZUMAB ANTIBODIES
29
Patent #:
NONE
Issue Dt:
Application #:
13264983
Filing Dt:
02/13/2012
Publication #:
US20120135005
Pub Dt:
05/31/2012
Title:
ANTI-TNF-a ANTIBODIES AND THEIR USES
30
Patent #:
NONE
Issue Dt:
Application #:
13481081
Filing Dt:
05/25/2012
Publication #:
US20120301429
Pub Dt:
11/29/2012
Title:
DAC HYP COMPOSITIONS AND METHODS
Assignor
1
ABBOTT BIOTHERAPEUTICS CORP
Exec Dt:
11/28/2012
Assignee
1
ABBVIE BIOTHERAPEUTICS INC.
1500 SEAPORT BLVD
REDWOOD CITY, CALIFORNIA 94063
Correspondence name and address
ABBVIE BIOTHERAPEUTICS INC.
1500 SEAPORT BLVD
REDWOOD CITY, CA 94063

Search Results as of: 05/14/2024 11:40 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT